(Q35933994)

11 August 2017

Frequent gene amplification predicts poor prognosis in gastric cancer (English)

1 reference

11 August 2017

Jing Shi

1

1 reference

11 August 2017

Demao Yao

2

1 reference

11 August 2017

Wei Liu

3

1 reference

11 August 2017

Na Wang

4

1 reference

11 August 2017

Hongjun Lv

5

1 reference

11 August 2017

Nongyue He

6

1 reference

11 August 2017

Bingyin Shi

7

1 reference

11 August 2017

Peng Hou

8

1 reference

11 August 2017

Meiju Ji

9

1 reference

11 August 2017

language of work or name

English

0 references

publication date

13 April 2012

1 reference

International Journal of Molecular Sciences

11 August 2017

1 reference

11 August 2017

13

1 reference

11 August 2017

4

1 reference

11 August 2017

4714-4726

1 reference

Creative Commons Attribution 4.0 International

11 August 2017

start time

13 April 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

c-MET as a potential therapeutic target and biomarker in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Targeted therapies for gastric cancer: current status

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

New targeted therapies for gastric cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

2 October 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Clinical implications of MET gene copy number in lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Identification of gastric cancer stem cells using the cell surface marker CD44.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Gene amplification in cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Epidemiology of gastric cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Alterations of chromosomal copy number during progression of diffuse‐type gastric carcinomas: metaphase‐ and array‐based comparative genomic hybridization analyses of multiple samples from individual tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Surgical approaches and outcomes in the treatment of gastric cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Amplification of oncogenes in human cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FIJMS13044714

High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FIJMS13044714

High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3344242

Uncommon Mutation, but Common Amplifications, of thePIK3CAGene in Thyroid Tumors

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FIJMS13044714

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer

21 January 2018

1 reference

12 December 2020

Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer

1 reference

12 December 2020

Analysis of DNA copy number aberrations by multiple ligation-dependent probe amplification on 50 intestinal type gastric cancers

1 reference

12 December 2020

Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers

1 reference

12 December 2020

Targeting the c-MET signaling pathway for cancer therapy

1 reference

12 December 2020

PIK3CA gene amplification in Japanese non-small cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS13044714

1 reference

11 August 2017

1 reference

11 August 2017

1 reference